Powered by Clearbit
Coloplast A/S (NBB: CLPB Y)+ to Company Analysis List
Address: Holtedam 1,Humlebaek, 3050 Denmark  |  Phone: (45) 49 11 33 76  |  Fax: (45) 49 11 15 55  |  Company Website: www.coloplast.com

Incorporated: September 1957 , Denmark

Country:  Denmark

Industry: Medical Supplies (ICB 20102015)

Industry: Surgical appliances and supplies (SIC 3842)

Industry: Sanitary Paper Product Manufacturing (NAICS 322291)

Number of Employees: 14,783 (Year End Average Staff as of 09/30/2022)

Number of Shareholders: 53,712 (as of 09/30/2022)

Revenue: 27,030,000,000

Net Income: 5,052,000,000

Dividend: 0.2012    Dividend Yield: 1.8027

EPS Basic: 22.46    EPS Diluted: 22.46

Synopsis Highlights History Business Property Subsidiaries Long term debt Capital stock Earnings estimates Business segments
Download  Printer Friendly My Mergent Tools
Company Analysis List (0/500)
No company added to the Company Analysis List
Executive List (0/500)
No executive added to the Executive List
Mergent Private Company List (0/500)
No company added to the Mergent Private Company List
Company Alerts (0)
No alerts added to Alerts
Executive Alerts (0)
No alerts added to Executive Alerts

Business Summary

Coloplast is a consumer healthcare company. Co.'s operating segments are: Chronic Care, which covers the sale of ostomy care products and continence care products; Interventional Urology, which covers the sale of urological products, including disposable products, as well as research and development (R&D) activities; Wound and Skin Care, which covers the sale of wound and skin care products; and Voice and Respiratory Care, which covers the sale of laryngectomy and tracheostomy products, as well as R&D activities.





Pricing Summary


Time Period


 Yesterday5 Days30 Days
Close11.1611.2211.14
Volume127,945.0076,038.00N/A
 
52 Week High/Low : N/A - N/A
% Price Change (100 Days) : -15.90
200-Day Moving Avg. : 12.48


Company News







Corporate Events




Key Executives

  
Chief Executive Officer,President
 
  
Senior Vice President
 
  
Executive Vice President,Chief Financial Officer
 
  
Executive Vice President
 
  
Executive Vice President
 

Key Financials

(In DKK as of 09/30/2024)

Income Statement
Revenue27,030m
Net Income5,052m
EPS - Net Income - Diluted22.46
Revenue per Share119.86
Balance Sheet
Total Assets48,073m
Total Liabilities30,131m
Shareholders' Equity17,942m
Total Assets per Share213.34
Net Assets per Share79.62
Cash Flows
Cash from Operations2,766m
Cash from Investing-1,336m
Cash from Financing-1,518m
Cash Flow per Share12.30